查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1442588

全球活檢設備市場評估：按產品類型、應用、最終用戶、地區、機會、預測（2017-2031）

Biopsy Devices Market Assessment, By Product Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 228 Pages | 商品交期: 3-5個工作天內

價格

全球切片設備市場規模預計將從 2023 年的 31 億美元成長到 2031 年的 57.4 億美元，預測期內複合年增長率為 8.03%。

據預測，由於全球癌症發病率增加、活檢設備設計和功能的進步、對微創手術的需求增加以及監管支持等增長因素的影響，活檢設備市場預計將增長。 此外，人工智慧和機器學習的整合預計將在活檢設備行業的持續成長和創新中發揮關鍵作用。 全球癌症患者數量的增加是推動活檢設備需求的主要驅動因素。 醫療基礎設施的擴大、診斷實驗室數量的增加以及政府透過準確、快速的診斷來減輕癌症疾病負擔的支持也是促進活檢設備市場擴大的因素。 此外，人們對癌症的認識不斷提高以及診斷方法的便捷獲取也推動了市場的成長。

另一方面，與使用活檢設備相關的感染風險和不發達的醫療基礎設施是阻礙市場成長的因素之一。 活檢過程中感染傳播的可能性很高，不僅對醫護人員而且對病人構成重大挑戰。

切片設備的進展

活檢設備的最新進展集中在液體活檢和骨骼活檢設備。 液體活檢分析來自體液的腫瘤來源信息，近年來在微光子學、奈米光子學和微流體技術進步的支持下取得了巨大進展。 這些技術能夠檢測循環腫瘤 RNA、無細胞 microRNA 和外泌體等分析物，與傳統組織活檢相比具有多種優勢，包括非侵入性、重現性和快速結果。 另一方面，骨骼活檢設備旨在收集小骨樣本進行測試，這有助於早期發現和診斷癌症等疾病。 骨骼活檢技術的最新進展包括創新設備的開發、組織採集技術的改進以及能夠進入難以到達的腫瘤部位的磁針的探索。

癌症病人增加

由於需要早期檢測和準確診斷疾病，越來越多的癌症患者增加了對活檢設備的需求。 乳癌、肺癌、白血病等各種癌症的盛行率不斷上升，對活檢設備的需求產生了積極影響。 癌症患者數量的增加是由於多種因素造成的，包括輻射暴露增加、生活方式不當、工作時間長、壓力增加、吸煙、飲酒和使用避孕措施。 據泛美衛生組織稱，全球約有 2,000 萬新發癌症病例和 1,000 萬癌症相關死亡病例。 這給衛生系統、個人和社區帶來了巨大的負擔。 不幸的是，預計這一負擔在未來 20 年將增加 60%。 這意味著到 2040 年，全球可能會新增約 3,000 萬癌症病例，預計增幅最顯著的將出現在低收入和中等收入國家。

北美成為主要地區

北美擁有較高的醫療保健支出、成熟的研發生態系統，並且注重早期疾病檢測。 北美還擁有強大的醫療基礎設施、完善的保險和自付系統以及積極的監管框架，這為該地區帶來了優勢。 該地區癌症和其他慢性病的盛行率也很高，導致對活檢設備的強勁需求。 此外，北美的主要進入者的存在以及對監管審批的關注也有助於北美在活檢設備市場的主導地位。

本報告調查了全球活檢設備市場，提供了市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構以及影響市場成長的因素。我們編制分析、案例研究、競爭格局、主要公司簡介等等。

目錄

第 1 章研究方法

第 2 章專案範圍與定義

第 3 章執行摘要

第 4 章全球切片設備市場展望

  • 市場規模/預測
  • 依產品類型
    • 針式切片槍
    • 切片引導系統
    • 切片鉗
    • 切片針
    • 其他
  • 依用途
    • 乳房切片檢查
    • 肺活檢
    • 大腸活檢
    • 攝護腺切片檢查
    • 其他
  • 按最終用戶
    • 醫院
    • 專科腫瘤中心
    • 診斷中心
    • 研究院
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美洲
    • 中東/非洲
  • 各公司的市佔率

第 5 章全球切片設備市場展望：按地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東/非洲

第 6 章市場映射

  • 依產品類型
  • 依用途
  • 按最終用戶
  • 按地區

第 7 章宏觀環境與產業結構

  • 需求與供給分析
  • 匯入/匯出分析
  • 價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第 8 章市場動態

  • 生長促進因素
  • 生長抑制因素（問題/抑制因素）

第 9 章法律與監管架構/創新

  • 臨床試驗
  • 專利環境
  • 監理機關核准
  • 創新/新興技術

第 10 章主要公司狀況

  • 前 5 名市場領導者的競爭矩陣
  • 前 5 位市場領導者的市場收入分析
  • 併購/合資企業（如果適用）
  • SWOT 分析（5 家參與公司）

第 11 章價格分析

第 12 章案例研究

第 13 章主要公司展望

  • Becton, Dickinson and Company
  • Hologic Inc.
  • Danaher Corporation
  • Cook Medical
  • Boston Scientific Corporation
  • Argon Medical Devices
  • B. Braun Melsungen AG
  • Cardinal Health Inc.
  • Medtronic PLC
  • Olympus Corporation

第 14 章策略建議

第 15 章關於我們公司/免責聲明

Product Code: MX11056

Global biopsy devices market is projected to witness a CAGR of 8.03% during the forecast period 2024-2031, growing from USD 3.1 billion in 2023 to USD 5.74 billion in 2031. The biopsy devices market is anticipated to thrive under the influence of growth factors like the growing prevalence of cancer cases globally, design and working advancements in biopsy devices, rising demand for minimally invasive procedures, and regulatory support. Additionally, the integration of artificial intelligence and machine learning is expected to play a pivotal role in the continued growth and innovation of the biopsy devices industry. The rising number of cancer cases at the global level is a major driver that drives the demand for biopsy devices. Growing healthcare infrastructure, a rising number of diagnostic laboratories, and government support for reducing the cancer disease burden through precise and rapid diagnostics are some other factors contributing to the expansion of the biopsy devices market. Furthermore, growing cancer awareness among common people and easy access to diagnostic methods propels market growth.

However, risks of infections associated with the use of biopsy devices and underdeveloped healthcare infrastructure are some factors hindering the growth of this market. During the biopsy process, the chances of infection spreading are high, posing a significant challenge for healthcare professionals as well as the patient.

In May 2023, Argon Medical Devices announced the launch of SuperCore Advantage semi-automatic biopsy instrument which is the newest addition to the company's soft tissue biopsy product portfolio in the United States. The SuperCore Advantage is a disposable soft tissue biopsy instrument that provides a larger tissue sample for more accurate analysis.

Advancements in Biopsy Devices

Recent advancements have been made in biopsy devices, with a focus on liquid biopsies and bone biopsy devices. Liquid biopsies involve the analysis of tumor-derived information from body fluids and have seen significant progress in recent years, supported by the development of microphotonics, nanophotonics, and microfluidics technologies. These technologies enable the detection of analytes, such as circulating tumor RNA, cell-free micro-RNA, and exosomes, and offer several benefits over traditional tissue biopsies, including non-invasiveness, repeatability, and quick results. Meanwhile, bone biopsy devices are designed to remove small bone samples for examination, aiding in the early detection and diagnosis of diseases such as cancer. Recent advancements in bone biopsy technology include the development of innovative devices, improvements in tissue sampling techniques, and the exploration of magnetic needles that can access difficult-to-reach tumor sites.

In November 2023, Illumina Inc. introduced a new version of its TruSight Oncology 500 ctDNA assay, which is designed to provide genomic profiling for circulating tumor DNA (ctDNA) from the blood when tissue-based testing is not possible or to complement tissue-based testing. The new research assay, known as TruSight Oncology 500 ctDNA v2, is a distributed liquid biopsy assay that offers comprehensive genomic profiling (CGP) for ctDNA.

Growing Number of Cancer Cases

The growing number of cancer cases increases the demand for biopsy devices due to the need for early disease detection and accurate diagnosis. The rising prevalence of different types of cancers, such as breast cancer, lung cancer, and leukemia, is positively impacting the demand scenario for biopsy devices. The growing number of cancer cases is attributed to the growing exposure to radiation, inadequate lifestyle, longer working hours, increasing stress, smoking, alcohol consumption, use of contraception, and many more. According to the Pan America Health Organization, globally, around 20 million new cases of cancer and 10 million cancer-related deaths were reported. This puts a considerable burden on health systems, individuals, and communities. Unfortunately, it is predicted that this burden will increase by 60% over the next two decades. This means that by 2040, there could be about 30 million new cases of cancer worldwide, with the most significant increase happening in low- and middle-income countries.

Dominance of Needle-based Biopsy Guns Segment

The needle-based biopsy guns segment dominates the biopsy devices market, with the largest market share. Needle-based biopsy guns are preferred for their precise and minimally invasive tissue collection, aiding in the diagnosis of various medical conditions, especially cancers. Ongoing advancements in needle design for improved accuracy, enhanced safety features, and the integration of imaging technologies, such as ultrasound guidance, are contributing to the growth of this segment. Needle biopsies are minimally invasive procedures that can be performed quickly and with relatively low risk, making them preferable for both patients and healthcare providers. The increasing demand for the gentle and rapid procurement of cell samples for biopsy is also contributing to the growth of this segment.

In October 2023, Praxis Medical obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its EndoCore Endobronchial ultrasound with transbronchial needle aspiration (EBUS-TBNA) fine needle biopsy device. This American medical device company has created the EndoCore EBUS-TBNA biopsy device to aid in the diagnosis and staging of lung cancer. The procedure involves inserting a long, flexible tiny needle through a bronchoscope to perform a biopsy and pathological analysis.

Breast Biopsy Segment to Dominate the Market

The breast cancer segment is expected to dominate the global biopsy devices market. Breast cancer, being the most prevalent type of cancer, takes up the major share in the biopsy device market. The increasing number of breast cancer screening programs and the emergence of liquid biopsy and promising clinical trials are driving this growth. Manufacturers are attempting efforts to cater to the significantly high demand for breast cancer biopsy devices. For instance, in March 2023, TransMed7, LLC announced the first clinical use of VacuPac, which is a new self-contained external vacuum-assist attachment. It comes with a SpeedBird Universal and a Concorde US from the SpeedBird and Concorde families of vacuum-assisted, Single Insertion - Multiple Collection (SIMC) breast biopsy devices. This announcement comes after the previous announcements made by TransMed7 in August 2022 and February 2023 about the first clinical uses of SpeedBird and Concorde biopsy devices. These announcements were made as part of the commercial launch of TransMed7's vacuum assisted, SIMC breast biopsy devices.

North America to be the Dominating Region

North America is the leading region in the biopsy devices market, which is due to several factors. The region has a high healthcare expenditure, a robust research and development ecosystem, and an emphasis on early disease detection. Additionally, North America benefits from a strong healthcare infrastructure, a well-established system for insurance and co-payment, and a proactive regulatory framework, which further reinforces its dominance. The region also has a high prevalence of cancer and other chronic diseases, leading to a robust demand for biopsy devices. Furthermore, the presence of key market players and a focus on regulatory approvals in North America contributes to its leading position in the biopsy devices market.

For instance, in September 2023, Limaca Medical received clearance from the United States Food and Drug Administration (FDA) for its Precision GI endoscopic ultrasound (EUS) biopsy device. The FDA granted the device a breakthrough device designation, and with this new approval, Limaca Medical's automated device can obtain biopsies for definitive pancreatic cancer and gastrointestinal cancer diagnoses more quickly and with less trauma than existing products.

Future Market Scenario (2024 - 2031F)

The regulatory emphasis on biopsy devices is evident in the FDA regulations, which classify biopsy devices used in gastroenterology and urology under three categories, gastroenterology-urology biopsy instruments, endoscopes and accessories, and endoscopic electrosurgical units and accessories. The development of liquid biopsies for cancer screening also requires careful planning to meet regulatory demands, with evolving regulatory pathways and the need for analytical and clinical validation studies. The regulatory strategies for liquid biopsy diagnostics depend on a framework developed by the US Food and Drug Administration, with evolving guidance documents and regulatory approval precedents. The complexity of regulatory permutations for liquid biopsy diagnostics is influenced by specific indications and companion diagnostic claims associated with the products. Conclusively, a rising number of regulatory-approved biopsy devices is anticipated to cultivate healthy competition in the market and contribute to its expansion.

For instance, in November 2023, Single Pass, Inc. announced that it has received a CE Mark under EU MDR for its Kronos Biopsy Closure device. The cautery device is useful in stopping bleeding caused by biopsy tools during co-axial biopsy procedures. It is most used in liver, kidney, lung, and breast biopsy procedures.

Key Players Landscape and Outlook

The key players in the biopsy devices market include both global as well as local companies that operate in the market through a vast network of distributors. Some of the major players in the global biopsy devices market are Becton, Dickinson and Company, Hologic Inc., Danaher Corporation, Cook Medical, Boston Scientific Corporation, Argon Medical Devices, and B. Braun Melsungen AG. These companies are mainly involved in the strategic product development, research, and approval process. Various mergers and acquisitions and collaborations have been observed in recent years, showing the activeness of the key market players.

In June 2023, Quest Diagnostics, a prominent provider of diagnostic information services, announced the completion of its acquisition of Haystack Oncology. The latter is a company that has developed a highly sensitive minimal-residual disease (MRD) testing technology, which is based on circulating tumor DNA (ctDNA). This technology can aid in the early detection of residual or recurring cancer and better inform therapy decisions. Quest plans to incorporate this MRD technology into the development of new blood-based clinical lab services for solid tumor cancers, which will be available starting in 2024.

In March 2023, OraSure collaborated with nRichDx to offer products for researchers who are developing urine-based liquid biopsy assays. Colli-Pee, a sample collection and preservation device, is created by OraSure's subsidiary Novosanis. This device uses a proprietary reagent that allows hygienic collection of a consistent, volumetric first-void urine sample. It also preserves cell-free nucleic acids, such as cfDNA and cfRNA. At the same time, the Revolution Sample Prep System, which has been developed by nRichDX in Irvine, CA, is a semi-automated cfDNA sample prep system. It can process up to 20 mL of urine in a single extraction.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Biopsy Devices Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product Type
    • 4.2.1. Needle-based Biopsy Guns
      • 4.2.1.1. Vacuum-assisted Biopsy (VAB) Devices
      • 4.2.1.2. Fine Needle Aspiration Biopsy (FNAB) Devices
      • 4.2.1.3. Core Needle Biopsy (CNB) Devices
    • 4.2.2. Biopsy Guidance Systems
      • 4.2.2.1. Manual
      • 4.2.2.2. Robotic
    • 4.2.3. Biopsy Forceps
      • 4.2.3.1. General Biopsy Forceps
      • 4.2.3.2. Hot Biopsy Forceps
    • 4.2.4. Biopsy Needles
      • 4.2.4.1. Disposable
      • 4.2.4.2. Reusable
    • 4.2.5. Others
  • 4.3. By Application
    • 4.3.1. Breast Biopsy
    • 4.3.2. Lung Biopsy
    • 4.3.3. Colorectal Biopsy
    • 4.3.4. Prostate Biopsy
    • 4.3.5. Others
  • 4.4. By End-user
    • 4.4.1. Hospitals
    • 4.4.2. Specialized Oncology Centers
    • 4.4.3. Diagnostic Centers
    • 4.4.4. Research Institutes
  • 4.5. By Region
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
    • 4.5.4. South America
    • 4.5.5. Middle East and Africa
  • 4.6. By Company Market Share (%), 2023

5. Global Biopsy Devices Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product Type
      • 5.1.2.1. Needle-based Biopsy Guns
      • 5.1.2.1.1. Vacuum-assisted Biopsy (VAB) Devices
      • 5.1.2.1.2. Fine Needle Aspiration Biopsy (FNAB) Devices
      • 5.1.2.1.3. Core Needle Biopsy (CNB) Devices
      • 5.1.2.2. Biopsy Guidance Systems
      • 5.1.2.2.1. Manual
      • 5.1.2.2.2. Robotic
      • 5.1.2.3. Biopsy Forceps
      • 5.1.2.3.1. General Biopsy Forceps
      • 5.1.2.3.2. Hot Biopsy Forceps
      • 5.1.2.4. Biopsy Needles
      • 5.1.2.4.1. Disposable
      • 5.1.2.4.2. Reusable
      • 5.1.2.5. Others
    • 5.1.3. By Application
      • 5.1.3.1. Breast Biopsy
      • 5.1.3.2. Lung Biopsy
      • 5.1.3.3. Colorectal Biopsy
      • 5.1.3.4. Prostate Biopsy
      • 5.1.3.5. Others
    • 5.1.4. By End-user
      • 5.1.4.1. Hospitals
      • 5.1.4.2. Specialized Oncology Centers
      • 5.1.4.3. Diagnostic Centers
      • 5.1.4.4. Research Institutes
    • 5.1.5. United States*
      • 5.1.5.1. Market Size & Forecast
      • 5.1.5.1.1. By Value
      • 5.1.5.1.2. By Volume
      • 5.1.5.2. By Product Type
      • 5.1.5.2.1. Needle-based Biopsy Guns
      • 5.1.5.2.1.1. Vacuum-assisted Biopsy (VAB) Devices
      • 5.1.5.2.1.2. Fine Needle Aspiration Biopsy (FNAB) Devices
      • 5.1.5.2.1.3. Core Needle Biopsy (CNB) Devices
      • 5.1.5.2.2. Biopsy Guidance Systems
      • 5.1.5.2.2.1. Manual
      • 5.1.5.2.2.2. Robotic
      • 5.1.5.2.3. Biopsy Forceps
      • 5.1.5.2.3.1. General Biopsy Forceps
      • 5.1.5.2.3.2. Hot Biopsy Forceps
      • 5.1.5.2.4. Biopsy Needles
      • 5.1.5.2.4.1. Disposable
      • 5.1.5.2.4.2. Reusable
      • 5.1.5.2.5. Others
      • 5.1.5.3. By Application
      • 5.1.5.3.1. Breast Biopsy
      • 5.1.5.3.2. Lung Biopsy
      • 5.1.5.3.3. Colorectal Biopsy
      • 5.1.5.3.4. Prostate Biopsy
      • 5.1.5.3.5. Others
      • 5.1.5.4. By End-user
      • 5.1.5.4.1. Hospitals
      • 5.1.5.4.2. Specialized Oncology Centers
      • 5.1.5.4.3. Diagnostic Centers
      • 5.1.5.4.4. Research Institutes
    • 5.1.6. Canada
    • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product Type
  • 6.2. By Application
  • 6.3. By End-user
  • 6.4. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trials
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Becton, Dickinson and Company
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Hologic Inc.
  • 13.3. Danaher Corporation
  • 13.4. Cook Medical
  • 13.5. Boston Scientific Corporation
  • 13.6. Argon Medical Devices
  • 13.7. B. Braun Melsungen AG
  • 13.8. Cardinal Health Inc.
  • 13.9. Medtronic PLC
  • 13.10. Olympus Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 2. Global Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 3. Global Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 4. Global Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 5. Global Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global Biopsy Devices Market Share (%), By Region, 2017-2031F
  • Figure 7. North America Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 8. North America Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 9. North America Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 10. North America Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 11. North America Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America Biopsy Devices Market Share (%), By Country, 2017-2031F
  • Figure 13. United States Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 14. United States Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 15. United States Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 16. United States Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 17. United States Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 19. Canada Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 20. Canada Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 21. Canada Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 22. Canada Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 24. Mexico Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 25. Mexico Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 26. Mexico Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 27. Mexico Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 29. Europe Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 30. Europe Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 31. Europe Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 32. Europe Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Biopsy Devices Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 35. Germany Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 36. Germany Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 37. Germany Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 38. Germany Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 39. France Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 40. France Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 41. France Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 42. France Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 43. France Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 45. Italy Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 46. Italy Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 47. Italy Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 48. Italy Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 50. United Kingdom Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 51. United Kingdom Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 52. United Kingdom Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 53. United Kingdom Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 55. Russia Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 56. Russia Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 57. Russia Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 58. Russia Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 60. Netherlands Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 61. Netherlands Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 62. Netherlands Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 63. Netherlands Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 65. Spain Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 66. Spain Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 67. Spain Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 68. Spain Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 70. Turkey Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 71. Turkey Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 72. Turkey Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 73. Turkey Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 75. Poland Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 76. Poland Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 77. Poland Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 78. Poland Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 80. South America Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 81. South America Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 82. South America Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 83. South America Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America Biopsy Devices Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 86. Brazil Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 87. Brazil Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 88. Brazil Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 89. Brazil Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 91. Argentina Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 92. Argentina Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 93. Argentina Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 94. Argentina Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 97. Asia-Pacific Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 98. Asia-Pacific Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 99. Asia-Pacific Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific Biopsy Devices Market Share (%), By Country, 2017-2031F
  • Figure 101. India Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 102. India Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 103. India Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 104. India Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 105. India Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 106. China Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 107. China Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 108. China Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 109. China Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 110. China Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 112. Japan Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 113. Japan Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 114. Japan Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 115. Japan Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 117. Australia Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 118. Australia Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 119. Australia Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 120. Australia Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 122. Vietnam Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 123. Vietnam Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 124. Vietnam Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 125. Vietnam Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 127. South Korea Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 128. South Korea Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 129. South Korea Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 130. South Korea Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 132. Indonesia Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 133. Indonesia Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 134. Indonesia Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 135. Indonesia Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 137. Philippines Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 138. Philippines Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 139. Philippines Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 140. Philippines Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 143. Middle East & Africa Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 144. Middle East & Africa Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 145. Middle East & Africa Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa Biopsy Devices Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 149. Saudi Arabia Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 150. Saudi Arabia Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 151. Saudi Arabia Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 153. UAE Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 154. UAE Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 155. UAE Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 156. UAE Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa Biopsy Devices Market, By Value, in USD Billion, 2017-2031F
  • Figure 158. South Africa Biopsy Devices Market, By Volume, in Million Units, 2017-2031F
  • Figure 159. South Africa Biopsy Devices Market Share (%), By Product Type, 2017-2031F
  • Figure 160. South Africa Biopsy Devices Market Share (%), By Application, 2017-2031F
  • Figure 161. South Africa Biopsy Devices Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023